|
GB202100450D0
|
|
Transcranial ultrasound devices and methods
|
|
GB202017877D0
|
|
Live attenuated strain of streptococcus pneumoniae and pharmaceutical compositions comprising a live attenuated strain of S. pneumoniae
|
|
GB202016253D0
|
|
Particle processing
|
|
GB202015235D0
|
|
Anti-CD45 antibodies and related therapeutics
|
|
GB202010854D0
|
|
Piezoelectric and piezocatalytic materials; and methods of forming them
|
|
GB202005641D0
|
|
Gene therapy for bardet-biedl syndrome
|
|
GB202002202D0
|
|
Gene therapy
|
|
GB201918752D0
|
|
New therapy
|
|
GB201916135D0
|
|
Extracellular matrix gels, and organoid cultures comprising the same
|
|
GB201913141D0
|
|
Methods and apparatuses for fabricating polymeric conformal coatings, parts coated with polymeric conformal coatings, and optical apparatus
|
|
GB201913140D0
|
|
Methods and apparatuses for fabricating polymeric conformal coatings, parts coated with polymeric conformal coatings, and optical apparatus
|
|
GB201912712D0
|
|
A settlement monitoring system and method
|
|
WO2020039183A1
|
|
Factor ix encoding nucleotides
|
|
GB201911286D0
|
|
Method
|
|
GB201910756D0
|
|
Ultrasound registration
|
|
GB201909976D0
|
|
Low-temperature radio-frequency tuning circuit
|
|
GB201908591D0
|
|
Methods for cancer diagnosis
|
|
GB201907093D0
|
|
Antibody functionalisation
|
|
GB201906914D0
|
|
Substituted naphtahlene diimdes and their use
|
|
GB201906708D0
|
|
Novel compounds
|
